Workflow
扁鹊SAAS智慧体检数字化管理平台
icon
Search documents
回应客户需求 美年健康升级十大举措如何破解体检痛点?
Bei Jing Qing Nian Bao· 2025-09-25 12:38
提到体检,很多人的心情难免有些复杂:一方面,它是我们健康意识的"启蒙者"、疾病筛查的"防火 墙";另一方面,传统体检中千篇一律的项目、流水线式的流程、漫长的等待、粗略的报告解读和"检完 不管"的模式,也常让人感到无奈。"防患于未然,治病于未病",体检的本质应是一种超前于疾病的关 怀与守护。直面客户需求和痛点,美年健康以"ALL in AI"为核心战略,借助人工智能全面升级服务流 程,推动体检行业走向智能化、个性化,并于近期正式推出2025客户服务创新升级十大举措。这一系列 举措不仅提升了体检的效率和精准度,更延伸了服务链条,真正实现"检得起、检得准、检后有人管", 深刻呼应了美年健康"以客户为中心"的服务理念。 体检过程中如何保证准确性?美年健康持续优化体检分院各工作岗位的规范化操作流程(SOP),要求 全体医技护人员必须严格按照SOP全面准确执行。在检查前提前告知客户操作流程,主动说明步骤和体 感;检查中"三查七对"确认客户信息,遵守"唱说唱检"制度,让每一步操作都透明无误。 预约不用挤,导检不迷路 AI让体检流程更顺畅 北青报记者梳理本次升级发布的十大措施发现,"以客户体验为先"贯穿始终。体检时,人多拥挤 ...
美年健康(002044):拟购买19家体检机构股权 发行股份助力规模扩张
Xin Lang Cai Jing· 2025-04-15 10:29
Group 1 - The company announced plans to acquire 19 health check institutions, increasing its control over these entities to 100% for 18 of them and 90% for one [1] - The total unaudited revenue for these 19 institutions in 2024 is projected to be 505 million, with a net profit of 52 million, resulting in a net profit margin of 10.26% [2] - The acquisition is expected to enhance the company's performance by increasing the number of controlled outlets and overall revenue [2] Group 2 - The company has initiated a comprehensive transformation since 2020, focusing on building a health industry ecosystem and has proposed an "All in AI" strategy in 2023 [2] - The company utilizes AI as a core tool to develop a digital management platform for health check services, enhancing the quality management system across the entire process [2] - The company has introduced innovative products targeting key medical disciplines, particularly in cancer early screening, to meet deep health check demands [2] Group 3 - The company has not adjusted its profit forecasts due to the unaudited performance of the acquired institutions, with projected revenues for 2024-2026 being 10.599 billion, 11.614 billion, and 12.731 billion respectively [3] - Expected net profits for 2024-2026 are projected to be 349 million, 562 million, and 798 million respectively, with growth rates of -31.0%, 61.2%, and 42.0% [3] - The corresponding price-to-earnings ratios for 2025-2026 are estimated to be 38 and 27 times, maintaining a "buy" rating [3]